High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Authors

  • Helen A. Rendall
  • Robert F. Marchington
  • Bavishna B. Praveen
  • Gerald Bergmann
  • Yoshihiko Arita
  • Alexander Heisterkamp
  • Frank J. Gunn-Moore
  • Kishan Dholakia

External Research Organisations

  • University of St. Andrews
  • Friedrich Schiller University Jena
View graph of relations

Details

Original languageEnglish
Title of host publicationFrontiers in Ultrafast Optics
Subtitle of host publicationBiomedical, Scientific, and Industrial Applications XIII
Publication statusPublished - 15 Mar 2013
Externally publishedYes
EventFrontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII - San Francisco, CA, United States
Duration: 3 Feb 20135 Feb 2013

Publication series

NameProceedings of SPIE - The International Society for Optical Engineering
Volume8611
ISSN (Print)0277-786X

Abstract

Femtosecond photoporation is an optical, non-invasive method of injecting membrane impermeable substances contained within the surrounding medium into cells. The technique typically addresses individual cells in a static monolayer. While this gives excellent selectivity, it can be time consuming or impractical to treat larger samples. We build on previous work using a microfluidic platform, which allows for a suspension of cells to be dosed with femtosecond light as they flow through a microfluidic channel. A reusuable quartz chip is designed with an 's'-bend with facilitates the delivery of a 'non-diffracting' femtosecond Bessel beam along the centre of the channel. By implementing off-chip hydrodynamic focusing, cells are confined to the central region of the channel and pass along the Bessel beam core where they are photoporated. This new parallel approach allows for higher flow rates to be used compared to the previous, orthogonal, design whilst maintaining the necessary dwell time in the Bessel beam core. Optical injection of the cell membrane impermeable stain propidium iodide has been successful with two cell lines. These have yielded viable injection efficiencies of 31.0±9.5% Chinese hamster ovary cells (CHO-K1) and 20.4±4.2% human promyelocytic cells (HL60) with a cell throughput of up to 10 cells/second. This marks an order of magnitude increase compared to the previous microfluidic design.

Keywords

    Bessel beam, microfluidics, Optical injection, photoporation

ASJC Scopus subject areas

Cite this

High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform. / Rendall, Helen A.; Marchington, Robert F.; Praveen, Bavishna B. et al.
Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII. 2013. 861103 (Proceedings of SPIE - The International Society for Optical Engineering; Vol. 8611).

Research output: Chapter in book/report/conference proceedingConference contributionResearchpeer review

Rendall, HA, Marchington, RF, Praveen, BB, Bergmann, G, Arita, Y, Heisterkamp, A, Gunn-Moore, FJ & Dholakia, K 2013, High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform. in Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII., 861103, Proceedings of SPIE - The International Society for Optical Engineering, vol. 8611, Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII, San Francisco, CA, United States, 3 Feb 2013. https://doi.org/10.1117/12.2003193
Rendall, H. A., Marchington, R. F., Praveen, B. B., Bergmann, G., Arita, Y., Heisterkamp, A., Gunn-Moore, F. J., & Dholakia, K. (2013). High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform. In Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII Article 861103 (Proceedings of SPIE - The International Society for Optical Engineering; Vol. 8611). https://doi.org/10.1117/12.2003193
Rendall HA, Marchington RF, Praveen BB, Bergmann G, Arita Y, Heisterkamp A et al. High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform. In Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII. 2013. 861103. (Proceedings of SPIE - The International Society for Optical Engineering). doi: 10.1117/12.2003193
Rendall, Helen A. ; Marchington, Robert F. ; Praveen, Bavishna B. et al. / High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform. Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII. 2013. (Proceedings of SPIE - The International Society for Optical Engineering).
Download
@inproceedings{46bf8fc263f84fb78e0044561a607202,
title = "High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform",
abstract = "Femtosecond photoporation is an optical, non-invasive method of injecting membrane impermeable substances contained within the surrounding medium into cells. The technique typically addresses individual cells in a static monolayer. While this gives excellent selectivity, it can be time consuming or impractical to treat larger samples. We build on previous work using a microfluidic platform, which allows for a suspension of cells to be dosed with femtosecond light as they flow through a microfluidic channel. A reusuable quartz chip is designed with an 's'-bend with facilitates the delivery of a 'non-diffracting' femtosecond Bessel beam along the centre of the channel. By implementing off-chip hydrodynamic focusing, cells are confined to the central region of the channel and pass along the Bessel beam core where they are photoporated. This new parallel approach allows for higher flow rates to be used compared to the previous, orthogonal, design whilst maintaining the necessary dwell time in the Bessel beam core. Optical injection of the cell membrane impermeable stain propidium iodide has been successful with two cell lines. These have yielded viable injection efficiencies of 31.0±9.5% Chinese hamster ovary cells (CHO-K1) and 20.4±4.2% human promyelocytic cells (HL60) with a cell throughput of up to 10 cells/second. This marks an order of magnitude increase compared to the previous microfluidic design.",
keywords = "Bessel beam, microfluidics, Optical injection, photoporation",
author = "Rendall, {Helen A.} and Marchington, {Robert F.} and Praveen, {Bavishna B.} and Gerald Bergmann and Yoshihiko Arita and Alexander Heisterkamp and Gunn-Moore, {Frank J.} and Kishan Dholakia",
year = "2013",
month = mar,
day = "15",
doi = "10.1117/12.2003193",
language = "English",
isbn = "9780819493804",
series = "Proceedings of SPIE - The International Society for Optical Engineering",
booktitle = "Frontiers in Ultrafast Optics",
note = "Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII ; Conference date: 03-02-2013 Through 05-02-2013",

}

Download

TY - GEN

T1 - High-throughput optical injection of mammalian cells using a non-diffracting beam in a microfluidic platform

AU - Rendall, Helen A.

AU - Marchington, Robert F.

AU - Praveen, Bavishna B.

AU - Bergmann, Gerald

AU - Arita, Yoshihiko

AU - Heisterkamp, Alexander

AU - Gunn-Moore, Frank J.

AU - Dholakia, Kishan

PY - 2013/3/15

Y1 - 2013/3/15

N2 - Femtosecond photoporation is an optical, non-invasive method of injecting membrane impermeable substances contained within the surrounding medium into cells. The technique typically addresses individual cells in a static monolayer. While this gives excellent selectivity, it can be time consuming or impractical to treat larger samples. We build on previous work using a microfluidic platform, which allows for a suspension of cells to be dosed with femtosecond light as they flow through a microfluidic channel. A reusuable quartz chip is designed with an 's'-bend with facilitates the delivery of a 'non-diffracting' femtosecond Bessel beam along the centre of the channel. By implementing off-chip hydrodynamic focusing, cells are confined to the central region of the channel and pass along the Bessel beam core where they are photoporated. This new parallel approach allows for higher flow rates to be used compared to the previous, orthogonal, design whilst maintaining the necessary dwell time in the Bessel beam core. Optical injection of the cell membrane impermeable stain propidium iodide has been successful with two cell lines. These have yielded viable injection efficiencies of 31.0±9.5% Chinese hamster ovary cells (CHO-K1) and 20.4±4.2% human promyelocytic cells (HL60) with a cell throughput of up to 10 cells/second. This marks an order of magnitude increase compared to the previous microfluidic design.

AB - Femtosecond photoporation is an optical, non-invasive method of injecting membrane impermeable substances contained within the surrounding medium into cells. The technique typically addresses individual cells in a static monolayer. While this gives excellent selectivity, it can be time consuming or impractical to treat larger samples. We build on previous work using a microfluidic platform, which allows for a suspension of cells to be dosed with femtosecond light as they flow through a microfluidic channel. A reusuable quartz chip is designed with an 's'-bend with facilitates the delivery of a 'non-diffracting' femtosecond Bessel beam along the centre of the channel. By implementing off-chip hydrodynamic focusing, cells are confined to the central region of the channel and pass along the Bessel beam core where they are photoporated. This new parallel approach allows for higher flow rates to be used compared to the previous, orthogonal, design whilst maintaining the necessary dwell time in the Bessel beam core. Optical injection of the cell membrane impermeable stain propidium iodide has been successful with two cell lines. These have yielded viable injection efficiencies of 31.0±9.5% Chinese hamster ovary cells (CHO-K1) and 20.4±4.2% human promyelocytic cells (HL60) with a cell throughput of up to 10 cells/second. This marks an order of magnitude increase compared to the previous microfluidic design.

KW - Bessel beam

KW - microfluidics

KW - Optical injection

KW - photoporation

UR - http://www.scopus.com/inward/record.url?scp=84878143782&partnerID=8YFLogxK

U2 - 10.1117/12.2003193

DO - 10.1117/12.2003193

M3 - Conference contribution

AN - SCOPUS:84878143782

SN - 9780819493804

T3 - Proceedings of SPIE - The International Society for Optical Engineering

BT - Frontiers in Ultrafast Optics

T2 - Frontiers in Ultrafast Optics: Biomedical, Scientific, and Industrial Applications XIII

Y2 - 3 February 2013 through 5 February 2013

ER -